Amgen Shares Rise 6% On Analysts Upgrade

Shares of biopharmaceutical company Amgen Inc. (AMGN) are rising 6 percent on Tuesday's trading after it was upgraded by analysts at Morgan Stanley from an "equal weight" rating to an "overweight" rating in a research report.

Currently at $246.40, the stock has traded between $198.64 and $258.45 during the past 52 weeks.

For comments and feedback contact: editorial@rttnews.com

Business News

Invest in the Best Biotech Stocks by Subscribing to RTT Biotech Investor.
Follow RTT